AUTHOREA
Log in Sign Up Browse Preprints

Are multiple sclerosis therapies safe in SARS-Cov-2 times?
Francesco Ferrara, Giovanni Granata, Chiara Pelliccia, et al.
Active agents of Renin Angiotensin System and SARS-CoV-2
Antonio Vitiello, Raffaele La Porta, Giovanni Granata, et al.
Plasma Therapy in the fight against Sars-CoV-2: what boils in the pot.
Antonio Vitiello, Francesco Ferrara, Raffaele La Porta, et al.
Clinical and phamacological analysis of Sars Cov 2: how combination therapy makes che...
Francesco Ferrara, Giovanni Granata, Chiara Pelliccia, et al.
Clinical pharmacology aspects in patients treated with TNF inhibitors during SARS-Cov...
Antonio Vitiello, Chiara Pelliccia, Francesco Ferrara, et al.
The added value of pirfenidone to declare war on inflammation and the fibrotic state...
Francesco Ferrara, Giovanni Granata, Chiara Pelliccia, et al.
Patient management positive covid: the central role of clinical nutrition and supplem...
Francesco Ferrara, Giovanni Granata, Chiara Pelliccia, et al.
What do we know about the correlation between RAS and SARS-Cov-2 infection?
Antonio Vitiello, Raffaele La Porta, Giovanni Granata, et al.
Current treatments and scientific advancements to combat the epidemic novel coronavir...
Francesco Ferrara, Chiara Pelliccia, Antonio Vitiello, et al.
Anti-rheumatic in SARS Cov 2: benefit or risk?
Francesco Ferrara, Chiara Pelliccia, Antonio Vitiello, et al.